Immediate and longer term immunogenicity of a single dose of the combined Haemophilus influenzae type b-Neisseria meningitidis serogroup c-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age

Pediatric Infectious Disease Journal

Volumn 30, Issue 4, 2011, Pages 340-342

  Booy, Robert ^a   Richmond, Peter ^b   Nolan, Terry ^c,d   McVernon, Jodie ^c,d   Marshall, Helen ^e   Nissen, Michael ^f   Reynolds, Graham ^g   Ziegler, John B ^h   Heron, Leon ^a   Lambert, Stephen ^f   Caubet, Magalie ⁱ   Mesaros, Narcisa ⁱ   Boutriau, Dominique ⁱ  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g CANBERRA HOSPITAL   (Australia)

^h SYDNEY CHILDREN'S HOSPITAL   (Australia)

ⁱ GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Antibody persistence; Haemophilus influenzae type b; Neisseria meningitidis serogroup C; Toddlers

Indexed keywords

BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B PLUS NEISSERIA MENINGITIDIS SEROGROUP C TETANUS TOXOID CONJUGATE VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MENITORIX; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; BACTERICIDAL ACTIVITY; CHILD; CONTROLLED STUDY; DRUG CONJUGATION; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TODDLER; VACCINATION;

EID: 79954690914     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31820013d2     Document Type: Article

References (13)

1. Pace D, Snape M, Westcar S, et al. A new combination Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants. Pediatr Infect Dis J. 2007;26:1057-1059. (Pubitemid 350287591)
2. Schmitt HJ, Maechler G, Habermehl P, et al. Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine. Clin Vaccine Immunol. 2007;14:426-434. (Pubitemid 46732554)
3. Tejedor JC, Moro M, Ruiz-Contreras J, et al. Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months. Pediatr Infect Dis J. 2007;26:1-7. (Pubitemid 46045743)
4. Pace D, Snape M, Westcar S, et al. A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial. Arch Dis Child. 2008;93:963-970.
5. Tejedor JC, Moro M, Merino JM, et al. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age. Pediatr Infect Dis J. 2008;27:579-588.
6. Carmona A, Miranda M, Barrio F, et al. Reactogenicity and immunogenicity of combined Haemophilus influenzae type b-meningococcal serogroup C conjugate vaccine booster dose coadministered with measles, mumps, and rubella vaccine. Pediatr Infect Dis J. 2010;29:269-271.
7. Borrow R, Balmer P, Miller E. Meningococcal surrogates of protection - serum bactericidal antibody activity. Vaccine. 2005;23:2222-2227. (Pubitemid 40341456)
8. Käyhty H, Peltola H, Karanko V, et al. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147:1100. (Pubitemid 13068358)
9. Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1984;149:1034-1035.
10. Richmond P, Borrow R, Goldblatt D, et al. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis. 2001;183:160-163. (Pubitemid 32043057)
11. Borrow R, Andrews N, Findlow H, et al. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin Vaccine Immunol. 2010;17:154-159.
12. Reid R, Santosham M, Croll J, et al. Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine. Pediatr Infect Dis J. 1993;12:812-815. (Pubitemid 23311590)
13. Greenberg DP, Lieberman JM, Marcy SM, et al. Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines. J Pediatr. 1995;126:206-211.